 Shares of Medpace Hldgs NASDAQ:MEDP moved higher by 15.7 in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share decreased 20.99 over the past year to 0.64, which beat the estimate of 0.40.Revenue of 204,995,000 decreased by 4.25 year over year, which beat the estimate of 174,970,000.Guidance The upcoming fiscal years EPS expected to be between 3.62 and 3.83.View more earnings on MEDPThe upcoming fiscal years revenue expected to be between 880,000,000 and 920,000,000.Price Action Companys 52-week high was at 114.1252-week low: 58.72Price action over last quarter: Up 33.19Company Description Medpace Holdings Inc is a clinical contract research organization. It is engaged in scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. It operates in North America, Europe, Africa, Middle East, Asia-Pacific and Latin America.See more from Benzinga Earnings Scheduled For July 27, 2020 Stocks That Hit 52-Week Highs On Thursday Stocks That Hit 52-Week Highs On WednesdayC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 